Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

NCT04842422 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT04842422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04842422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream
Lead sponsor
Medical University of Graz
Phase
Phase 4
Overall status
Completed
Start date
April 16, 2021
Completion date
August 23, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses